Fangyou Lin

548 total citations
25 papers, 379 citations indexed

About

Fangyou Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Fangyou Lin has authored 25 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Nephrology. Recurrent topics in Fangyou Lin's work include Kidney Stones and Urolithiasis Treatments (6 papers), Chronic Kidney Disease and Diabetes (6 papers) and Ferroptosis and cancer prognosis (5 papers). Fangyou Lin is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (6 papers), Chronic Kidney Disease and Diabetes (6 papers) and Ferroptosis and cancer prognosis (5 papers). Fangyou Lin collaborates with scholars based in China and France. Fangyou Lin's co-authors include Cheng Fan, Yuqi Xia, Weimin Yu, Ting Rao, Bojun Li, Zehua Ye, Xiangjun Zhou, Jinzhuo Ning, Xiangjun Zhou and Xing Ji and has published in prestigious journals such as Nature Communications, Medicine and Cell Death and Disease.

In The Last Decade

Fangyou Lin

23 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangyou Lin China 11 177 161 101 48 36 25 379
Huzi Xu China 9 278 1.6× 170 1.1× 135 1.3× 90 1.9× 42 1.2× 16 473
Yongchang Lai China 13 277 1.6× 260 1.6× 140 1.4× 21 0.4× 20 0.6× 37 505
Boxing Su China 11 191 1.1× 111 0.7× 121 1.2× 24 0.5× 35 1.0× 28 397
Yuehan Wei China 8 145 0.8× 104 0.6× 66 0.7× 21 0.4× 46 1.3× 14 293
Lang Shi China 12 250 1.4× 69 0.4× 116 1.1× 83 1.7× 67 1.9× 24 448
Guoyu Dai China 9 170 1.0× 148 0.9× 128 1.3× 50 1.0× 31 0.9× 16 367
Jieping Hu China 13 230 1.3× 193 1.2× 102 1.0× 15 0.3× 16 0.4× 38 431
Juchao Ren China 14 225 1.3× 63 0.4× 107 1.1× 14 0.3× 43 1.2× 25 374

Countries citing papers authored by Fangyou Lin

Since Specialization
Citations

This map shows the geographic impact of Fangyou Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyou Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyou Lin more than expected).

Fields of papers citing papers by Fangyou Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyou Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyou Lin. The network helps show where Fangyou Lin may publish in the future.

Co-authorship network of co-authors of Fangyou Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyou Lin. A scholar is included among the top collaborators of Fangyou Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyou Lin. Fangyou Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Fangyou, et al.. (2025). The long non-coding RNA RSDR protects against acute kidney injury in mice by interacting with hnRNPK to regulate DHODH-mediated ferroptosis. Nature Communications. 16(1). 7483–7483. 1 indexed citations
2.
Ye, Zehua, Shuqin Mei, Miao Zhang, et al.. (2025). PRMT1-mediated methylation of UBE2m promoting calcium oxalate crystal-induced kidney injury by inhibiting fatty acid metabolism. Cell Death and Disease. 16(1). 579–579. 1 indexed citations
3.
5.
Guo, Jiayu, Jun Li, Fangyou Lin, et al.. (2024). ANKRD1 aggravates renal ischaemia‒reperfusion injury via promoting TRIM25‐mediated ubiquitination of ACSL3. Clinical and Translational Medicine. 14(9). e70024–e70024. 6 indexed citations
6.
Chen, Lijia, et al.. (2024). The bach1/G9a/Slc7a11 axis epigenetically promotes renal fibrosis by mediated ferroptosis. International Immunopharmacology. 143(Pt 1). 113363–113363. 4 indexed citations
7.
Xia, Yuqi, Bojun Li, Zehua Ye, et al.. (2024). The SOX4/EZH2/SLC7A11 signaling axis mediates ferroptosis in calcium oxalate crystal deposition-induced kidney injury. Journal of Translational Medicine. 22(1). 9–9. 30 indexed citations
8.
Li, Bojun, Yuqi Xia, Shuqin Mei, et al.. (2023). Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI. Theranostics. 13(6). 1860–1875. 57 indexed citations
9.
Xia, Yuqi, Bojun Li, Ting Rao, et al.. (2023). Gut microbiota in patients with kidney stones: a systematic review and meta-analysis. BMC Microbiology. 23(1). 143–143. 39 indexed citations
10.
Lin, Fangyou, Bojun Li, Weimin Yu, et al.. (2023). Classification and clinical significance of the posterior group of renal calyces. Medicine. 102(31). e34443–e34443. 1 indexed citations
11.
Ye, Zehua, Yuqi Xia, Bojun Li, et al.. (2023). YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones. Biomedicines. 11(10). 2692–2692. 17 indexed citations
12.
Li, Bojun, Fangyou Lin, Yuqi Xia, et al.. (2022). The Intersection of Acute Kidney Injury and Non-Coding RNAs: Inflammation. Frontiers in Physiology. 13. 923239–923239. 5 indexed citations
13.
Lin, Fangyou, Cong Liu, Yuqi Xia, et al.. (2022). HO‐1 Contributes to Luteolin‐Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. Oxidative Medicine and Cellular Longevity. 2022(1). 3846217–3846217. 75 indexed citations
14.
Lin, Fangyou, Bojun Li, Ting Rao, et al.. (2022). Presence of a Novel Anatomical Structure May Cause Bleeding When Using the Calyx Access in Mini-Percutaneous Nephrolithotomy. Frontiers in Surgery. 9. 942147–942147.
15.
Lin, Fangyou, Lei Xu, Run Yuan, et al.. (2022). Identification of inflammatory response and alternative splicing in acute kidney injury and experimental verification of the involvement of RNA‑binding protein RBFOX1 in this disease. International Journal of Molecular Medicine. 49(3). 13 indexed citations
16.
Ji, Xing, Chen Wu, Kang Chen, et al.. (2022). TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB. Cancers. 14(19). 4809–4809. 17 indexed citations
17.
Xia, Yuqi, Xiangjun Zhou, Zehua Ye, et al.. (2021). Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones. Frontiers in Genetics. 12. 774155–774155. 14 indexed citations
18.
Lin, Fangyou, Yuan Ruan, Sheng Zhao, et al.. (2021). miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway. International Immunopharmacology. 99. 108022–108022. 27 indexed citations
19.
Xia, Yuqi, Weimin Yu, Cheng Fan, et al.. (2021). Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression. Frontiers in Oncology. 11. 701122–701122. 13 indexed citations
20.
Lin, Fangyou, Weimin Yu, Ting Rao, et al.. (2018). The Anatomic Structure of a Fused Renal Pyramid and Its Clinical Significance in the Establishment of Percutaneous Renal Access. Urology. 124. 38–45. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026